Bulletin

Investor Alert

Tokyo Markets Open in:

US Market Snapshot Currencies Commodities

Teva Pharmaceutical Industries Ltd. ADR

NYS: TEVA

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Teva Pharmaceutical Industries Ltd. ADR

After Hours

--Real time quotes

May 24, 2022, 6:31 p.m.

TEVA

/zigman2/quotes/205657894/composite

8.50

Change

+0.05 +0.59%

Volume

Volume 38,551

Real time quotes

/zigman2/quotes/205657894/composite

Today's close

$ 8.45

Change

0.00 0.00%

Day low

Day high

$8.26

$8.50

52 week low

52 week high

$7.23

$11.55

Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Teva Pharmaceutical Industries Ltd. ADR

View Ratios

Assets

Fiscal year is January-December. All values ILS millions.	2017	2018	2019	2020	2021
Cash & Short Term Investments	3.4B	6.66B	6.82B	6.99B	6.74B
Cash Only	3.34B	6.66B	6.82B	6.99B	6.74B
Short-Term Investments	59.02M	-	-	-	-
Cash & Short Term Investments Growth	-	95.72%	2.44%	2.47%	-3.60%
Cash & ST Investments / Total Assets	1.39%	2.94%	3.44%	4.30%	4.54%
Total Accounts Receivable	24.75B	21.76B	19.6B	14.71B	14.1B
Accounts Receivables, Net	24.75B	21.76B	19.6B	14.71B	14.1B
Accounts Receivables, Gross	24.75B	21.76B	19.6B	15.11B	14.38B
Bad Debt/Doubtful Accounts	-	-	-	(404.56M)	(280.12M)
Other Receivables	-	-	-	-	-
Accounts Receivable Growth	-	-12.09%	-9.88%	-24.97%	-4.16%
Accounts Receivable Turnover	3.25	3.02	3.07	3.90	3.63
Inventories	17.09B	17.68B	15.27B	14.14B	11.88B
Finished Goods	9.34B	9.96B	8.65B	7.64B	6.01B
Work in Progress	2.07B	2.2B	2.01B	1.94B	1.83B
Raw Materials	5.05B	4.96B	4.09B	3.95B	3.54B
Progress Payments & Other	638.78M	553.04M	525.01M	606.84M	507.32M
Other Current Assets	8.16B	5.45B	4.8B	5.92B	6.41B
Miscellaneous Current Assets	4.34B	2.09B	1.8B	2.89B	3.07B
Total Current Assets	53.4B	51.54B	46.5B	41.76B	39.13B

	2017	2018	2019	2020	2021
Net Property, Plant & Equipment	26.64B	25.66B	24.01B	22.01B	20.16B
Property, Plant & Equipment - Gross	42.28B	44.08B	40.98B	38.36B	36.47B
Buildings	11.56B	11.71B	9.81B	8.73B	7.99B
Land & Improvements	1.35B	1.31B	1.12B	937.55M	815.45M
Computer Software and Equipment	-	-	-	-	-
Other Property, Plant & Equipment	7B	7.81B	7.36B	7.06B	7.04B
Accumulated Depreciation	15.64B	18.41B	16.97B	16.35B	16.31B
Total Investments and Advances	86.79M	216.73M	-	-	-
Other Long-Term Investments	86.79M	216.73M	-	-	-
Long-Term Note Receivable	-	-	-	-	-
Intangible Assets	159.88B	145.44B	124.61B	94.87B	85.61B
Net Goodwill	98.64B	93.11B	85.82B	66.22B	62.37B
Net Other Intangibles	61.24B	52.33B	38.8B	28.65B	23.24B
Other Assets	3.15B	2.51B	2.04B	1.73B	1.6B
Tangible Other Assets	3.15B	2.51B	2.04B	1.73B	1.6B
Total Assets	245.15B	226.76B	198.5B	162.59B	148.36B
Assets - Total - Growth	-	-7.50%	-12.46%	-18.09%	-8.76%

Liabilities & Shareholders' Equity

	2017	2018	2019	2020	2021
ST Debt & Current Portion LT Debt	12.66B	8.28B	8.51B	10.24B	4.78B
Short Term Debt	2.66B	1.93B	2.18B	1.65B	410.84M
Current Portion of Long Term Debt	10B	6.35B	6.32B	8.59B	4.37B
Accounts Payable	7.18B	6.92B	5.93B	5.64B	5.25B
Accounts Payable Growth	-	-3.60%	-14.30%	-4.98%	-6.93%
Income Tax Payable	-	-	-	-	-
Other Current Liabilities	42.37B	38.31B	32.79B	26.39B	24.3B
Dividends Payable	-	-	-	-	-
Accrued Payroll	1.91B	3.25B	2.39B	2.2B	1.75B
Miscellaneous Current Liabilities	40.47B	35.06B	30.4B	24.19B	22.54B
Total Current Liabilities	62.22B	53.52B	47.23B	42.27B	34.32B
Long-Term Debt	100.08B	99.77B	86.34B	74.52B	68.58B
Long-Term Debt excl. Capitalized Leases	100.08B	99.77B	84.84B	72.98B	67.28B
Non-Convertible Debt	100.08B	99.77B	84.84B	72.98B	67.28B
Convertible Debt	-	-	-	-	-
Capitalized Lease Obligations	-	-	-	-	-
Provision for Risks & Charges	-	-	-	-	-
Deferred Taxes	9.38B	6.62B	2.45B	863.71M	585.13M
Deferred Taxes - Credit	11.38B	8B	3.79B	3.1B	2.44B
Deferred Taxes - Debit	1.99B	1.38B	1.33B	2.23B	1.85B
Other Liabilities	6.4B	6.45B	9.12B	7.2B	8.02B
Other Liabilities (excl. Deferred Income)	6.4B	6.45B	9.12B	7.2B	8.02B
Deferred Income	-	-	-	-	-
Total Liabilities	180.07B	167.74B	146.47B	127.08B	113.36B
Non-Equity Reserves	-	-	-	-	-
Total Liabilities / Total Assets	73.45%	73.97%	73.79%	78.16%	76.41%
Preferred Stock (Carrying Value)	12.61B	-	-	-	-
Redeemable Preferred Stock	-	-	-	-	-
Non-Redeemable Preferred Stock	-	-	-	-	-
Common Equity (Total)	47.66B	54.96B	48.26B	32.19B	31.99B
Common Stock Par/Carry Value	187.47M	209.26M	193.42M	183.02M	177.41M
Retained Earnings	(13.2B)	(22.26B)	(24.03B)	(35.15B)	(32.77B)
ESOP Debt Guarantee	-	-	-	-	-
Cumulative Translation Adjustment/Unrealized For. Exch. Gain	(4.57B)	(7.02B)	(6.2B)	(6.16B)	(7.08B)
Unrealized Gain/Loss Marketable Securities	(13.89M)	3.74M	-	-	-
Revaluation Reserves	-	-	-	-	-
Treasury Stock	(14.4B)	(15.48B)	(14.26B)	(13.25B)	(12.85B)
Common Equity / Total Assets	19.44%	24.24%	24.31%	19.80%	21.56%
Total Shareholders' Equity	60.26B	54.96B	48.26B	32.19B	31.99B
Total Shareholders' Equity / Total Assets	24.58%	24.24%	24.31%	19.80%	21.56%
Accumulated Minority Interest	4.81B	4.06B	3.77B	3.32B	3.01B
Total Equity	65.08B	59.02B	52.03B	35.51B	35B
Liabilities & Shareholders' Equity	245.15B	226.76B	198.5B	162.59B	148.36B

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Copyright © 2022 MarketWatch, Inc. All rights reserved.
By using this site, you agree to the Subscriber Agreement & Terms of Use
Privacy Notice and Cookie Notice ().
Do Not Sell My Personal Information

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Teva Pharmaceutical Industries Ltd. ADR

Annual Financials for Teva Pharmaceutical Industries Ltd. ADR

Assets

Liabilities & Shareholders' Equity

Latest News

dow

nasdaq

s&p 500

Kiosk